Enduro Genetics, a synthetic biology startup, raised €12 million ($12.4 million) in Series A funding from Supernova Invest, NOON Ventures, and Sandwater. The funding will be used to expand Enduro’s ...

Skylark Bio (“Skylark”), a clinical-stage biotechnology company developing targeted genetic medicines for hearing loss, and Forge Biologics (“Forge”), a leading manufacturer of gene therapies and ...

An initial genome-wide analysis sheds light on Faroese ancestry and recent selection, and lays a foundation for understanding the genetics behind health and disease within this population.

Looking to expand its legacy in metabolic conditions, Novo Nordisk has inked a multiyear research pact with Variant Bio to better understand the genetics underlying disease across diverse populations.

Engage Biologics Inc. (“Engage”), a preclinical biotechnology company pioneering non-viral DNA delivery, today announced that it has been acquired by Eli Lilly and Company (“Lilly”). Engage is ...

A graph-based computational tool for detecting previously invisible genetic mutations has been developed. Researchers at the University of California, Los Angeles (UCLA; USA) and the University of ...

Yeast’s emergence as a model organism reshaped scientific discovery in cell biology, genetics, and more. Yeast is a ...

A global team has analyzed data from nearly 2 million individuals, uncovering new genes and genetic pathways underpinning osteoarthritis. A global collaboration of researchers led by Helmholtz Munich ...

Mo Khalil is the Hok Lam and Kathleen Kam Wong Professor of Bioengineering and Professor of Molecular and Cellular Biology at the Harvard John A. Paulson School of Engineering and Applied Sciences ...